Innoviva, Inc. - Feb 18, 2022 Form 4 Insider Report for Entasis Therapeutics Holdings Inc. (ETTX)

Role
10%+ Owner
Signature
INNOVIVA, INC., by /s/ Pavel Raifeld, Chief Executive Officer
Stock symbol
ETTX
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 12:05 PM
Previous filing
Feb 11, 2022
Next filing
Apr 1, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ETTX Common Stock 18.7M Feb 18, 2022 Direct F1
holding ETTX Common Stock 10M Feb 18, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETTX Convertible Promissory Note Other 0 0 Feb 18, 2022 Common Stock $1.48 See footnote F3
transaction ETTX Warrants to Purchase Common Stock Other 0 0% 10M Feb 18, 2022 Common Stock $1.48 See footnotes F2, F3
holding ETTX Warrants to Purchase Common Stock 18.7M Feb 18, 2022 Common Stock Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1
F2 See Exhibit 99.1
F3 See Exhibit 99.1